This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as depression, anxiety, and other mood-related conditions. Its structural features make it valuable for modifying pharmacological properties, enhancing drug efficacy, and improving selectivity for specific biological targets. Additionally, it is explored in the development of potential treatments for chronic pain and neurodegenerative diseases due to its ability to interact with neurotransmitter systems. Its application extends to preclinical studies, where it aids in understanding drug-receptor interactions and optimizing drug candidates for further clinical trials.